Cary Miller Ph.D.

Dr. Cary Miller's practice focuses on assisting life sciences clients with their patent issues. She works with clients in patent prosecution, prelitigation analysis, PTAB proceedings, and patent litigation. Prior to joining Jones Day, Cary participated in numerous biotechnology and pharmaceutical patent lawsuits including representing companies in Hatch-Waxman litigation, biosimilars litigation, and in litigation relating to DNA sequencing.

Cary has drafted and prosecuted patents relating to breakthrough therapies in a number of areas, including antibodies, cancer therapeutics and diagnostics, small molecules, human embryonic stem cells, and drug delivery devices. She has conducted intellectual property due diligence studies and has filed more than a dozen patent term extension applications for drugs and medical devices in the last two years. [1]